A Phase 1b Study of WU-NK-101 in Combination With Cetuximab

Clinical trial NCT05674526 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05674526
Sponsor: Allotera Therapeutics
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Metastatic Squamous Cell Carcinoma of Head and Neck

Start date: 2024-05-21
Primary completion: 2025-09-30
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.